Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Cash & Equivalents: 2021-2022

Historic Cash & Equivalents for Milestone Pharmaceuticals (MIST) over the last 2 years, with Sep 2022 value amounting to $77.2 million.

  • Milestone Pharmaceuticals' Cash & Equivalents fell 38.92% to $77.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $77.2 million, marking a year-over-year decrease of 38.92%. This contributed to the annual value of $114.1 million for FY2021, which is N/A change from last year.
  • As of Q3 2022, Milestone Pharmaceuticals' Cash & Equivalents stood at $77.2 million, which was down 10.44% from $86.2 million recorded in Q2 2022.
  • Milestone Pharmaceuticals' Cash & Equivalents' 5-year high stood at $135.8 million during Q2 2021, with a 5-year trough of $77.2 million in Q3 2022.
  • Over the past 2 years, Milestone Pharmaceuticals' median Cash & Equivalents value was $114.1 million (recorded in 2021), while the average stood at $110.0 million.
  • Data for Milestone Pharmaceuticals' Cash & Equivalents shows a maximum YoY plummeted of 38.92% (in 2022) over the last 5 years.
  • Quarterly analysis of 2 years shows Milestone Pharmaceuticals' Cash & Equivalents stood at $114.1 million in 2021, then slumped by 38.92% to $77.2 million in 2022.
  • Its Cash & Equivalents was $77.2 million in Q3 2022, compared to $86.2 million in Q2 2022 and $100.2 million in Q1 2022.